Conversely, DUSP6 knockdown in parental HS-SY-II cells apparently induced pazopanib resistance, accompanied by an increase in phosphorylated ERK1/2 (Fig. 4e and g), which recapitulated the acquired resistance to pazopanib in SS cells. This evidence concerns the gene MAPK3 and synovial sarcoma.